Botanical species · safety record

Chrysanthemum morifolium

The EFSA Compendium of Botanicals holds 12 constituent measurements and 6 adverse-effect records for Chrysanthemum morifolium. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Chrysanthemum morifolium Ramat.

12Constituent measurements

6Safety records

6Cited sources

57Licensed products (Canada)

Also recorded as

Chrysanthemum sinense Sabine ex Sweet

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 57 licensed products naming Chrysanthemum morifolium as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

Capitulum
Dried capitulum
Flower
Fruit spike

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Sesquiterpene lactones	Flower	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
(-)-pinocamphone	Flower	Essential oil	—	Unspecified	No resolvable identifier
1,8-cineole	Flower	Essential oil	—	Unspecified	No resolvable identifier
1,8-cineole	Unspecified	Essential oil	—	GC-MS	No resolvable identifier
Alpha-thujone	Unspecified	Solvent extraction	6.14 Milligram/litre	GC-FID-MS	No resolvable identifier
Camphor	Flower	Essential oil	—	Unspecified	No resolvable identifier
Camphor	Unspecified	Essential oil	—	GC-MS	No resolvable identifier
Coumarin	Unspecified	Solvent extraction	0.04 Milligram/litre	GC-FID-MS	No resolvable identifier
Eucarvone	Flower	Essential oil	—	Unspecified	No resolvable identifier
Eugenol	Flower	Essential oil	—	Unspecified	No resolvable identifier
Myrcene	Leaves	Essential oil	4.4 Percent	GC-MS	No resolvable identifier
Parthenolide	Unspecified	Solvent extraction	—	Unspecified	No resolvable identifier

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive	Flower	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang, Jiancheng., Li, Songjian., Li, Shenheng., Niu, Hongxin., Zhou, Weidong., Long, Haibo. Research progress of effects of parthenolide on oxidation stress. Zhongyao xinyao yu linchuang yaoli, 2012, p. 595-598.
Bahadur, Rajendra., Gupta, Gopi Nath. Essential oils from Chrysanthemum morifolium leaves. Riechstoffe, aromen, koerperpflegemittel, 1967, p. 60-62.
Nguyen Thi Luyen., Le Hoang Tram., Tran Thi Hong Hanh., Pham Thanh Binh., Nguyen Hai Dang., Chau Van Minh., Nguyen Tien Dat. Inhibitors of alpha-glucosidase, alpha-amylase and lipase from Chrysanthemum morifolium . Phytochemistry letters, 2013, vol. 6, no. 3, p. 322-325. DOI
Jo, Jung Ok., Kim, Sun Min., Kim, Kyong Su. Analysis of asarone, coumarin and thujone in medicinal plants used in brewing a Korean traditional folk wine. Han'guk nonghwa hakhoechi, 1999, p. 210-217.
Ito, Tetsuo., Tada, Shizuo., Sato, Shigemi. Aroma constituents of edible chrysanthemum. Iwate daigaku nogakubu hokoku, 1990, p. 35-42.
Liu, Ji-jin., Wang, Xiao-wei., Huang, Fu-xi., Xiong, Ying., Wu, Qiu-yun. GC determination of eucalyptol, camphor, borneol and bornyl acetate in volatile oil from Chrysanthemum morifolium. Zhongcaoyao, 2006, p. 1352-1353.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature